- Home
- RFL vs FSEA Comparison
RFL vs FSEA Comparison
Compare RFL & FSEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RFL
- FSEA
- Stock Information
- Founded
- RFL 2017
- FSEA 1890
- Country
- RFL United States
- FSEA United States
- Employees
- RFL N/A
- FSEA N/A
- Industry
- RFL Real Estate
- FSEA Savings Institutions
- Sector
- RFL Finance
- FSEA Finance
- Exchange
- RFL Nasdaq
- FSEA Nasdaq
- Market Cap
- RFL 48.4M
- FSEA 44.2M
- IPO Year
- RFL N/A
- FSEA N/A
- Fundamental
- Price
- RFL $2.14
- FSEA $9.07
- Analyst Decision
- RFL
- FSEA
- Analyst Count
- RFL 0
- FSEA 0
- Target Price
- RFL N/A
- FSEA N/A
- AVG Volume (30 Days)
- RFL 48.8K
- FSEA 10.3K
- Earning Date
- RFL 10-28-2024
- FSEA 11-07-2024
- Dividend Yield
- RFL N/A
- FSEA N/A
- EPS Growth
- RFL N/A
- FSEA N/A
- EPS
- RFL N/A
- FSEA N/A
- Revenue
- RFL $540,000.00
- FSEA $10,821,000.00
- Revenue This Year
- RFL N/A
- FSEA N/A
- Revenue Next Year
- RFL N/A
- FSEA N/A
- P/E Ratio
- RFL N/A
- FSEA N/A
- Revenue Growth
- RFL 92.86
- FSEA N/A
- 52 Week Low
- RFL $1.29
- FSEA $6.25
- 52 Week High
- RFL $2.14
- FSEA $9.49
- Technical
- Relative Strength Index (RSI)
- RFL 79.87
- FSEA 34.13
- Support Level
- RFL $2.00
- FSEA $9.00
- Resistance Level
- RFL $1.94
- FSEA $8.97
- Average True Range (ATR)
- RFL 0.09
- FSEA 0.06
- MACD
- RFL 0.02
- FSEA -0.02
- Stochastic Oscillator
- RFL 100.00
- FSEA 0.00
About RFL Rafael Holdings Inc. Class B
Rafael Holdings Inc, through its subsidiaries, is a clinical stage, oncology-focused pharmaceutical company committed to the development and commercialization of therapies that exploit the metabolic differences between normal cells and cancer cells. The company is a significant investor in two clinical stage oncology companies, Cornerstone Pharmaceuticals, Inc., and LipoMedix Pharmaceuticals Ltd.
About FSEA First Seacoast Bancorp Inc.
First Seacoast Bancorp Inc is a savings and loan holding company. Its business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations and borrowings from the Federal Home Loan Bank, in one-to-four-family residential real estate loans, commercial real estate, and multi-family real estate loans, acquisition, development and land loans, commercial and industrial loans, home equity loans and lines of credit and consumer loans. The company generates revenue from financial instruments, such as loans, letters of credit, and investment securities, as well as revenue related to mortgage servicing activities and bank-owned life insurance.